AnalystsBruce D. JacksonBruce D. Jackson's Stock Forecasts
AnalystsBruce D. Jackson
Sectors:
Analyst Ranking
Top 32%
#1606 out of 5116 analysts
Average Return
+39.41%
Win Rate
100%8 out of 8
Risk vs Reward
Poor
Good
Bruce D. Jackson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Harvard Bioscience IncHBIO | +69.49% | $0.45 | $0.76 | 2025-09-10 - 2025-11-28 | Buy |
Unicycive Therapeutics IncUNCY | +64.21% | $3.94 | $6.47 | 2025-09-15 - 2025-11-28 | Buy |
Clene IncCLNN | +60.12% | $6.47 | $10.36 | 2025-09-10 - 2025-11-28 | Strong Buy |
Exact Sciences CorpEXAS | +45.55% | $69.59 | $101.29 | 2025-11-04 - 2025-11-28 | Strong Buy |
Reviva Pharmaceuticals Holdings IncRVPH | +30.09% | $0.43 | $0.56 | 2025-09-15 - 2025-11-28 | Buy |
Bruce D. Jackson Analyst Color
Get additional color on Bruce D. Jackson's coverage of popular stocks
Bruce D. Jackson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Milestone Scientific IncMLSS | 1 | Buy | $1.00 | +218.47% | Maintains | 10 days ago |
Humacyte IncHUMA | 1 | Strong Buy | $11.00 | +714.81% | Maintains | 17 days ago |
Exact Sciences CorpEXAS | 1 | Strong Buy | $75.00 | -25.96% | Maintains | a month ago |
Belite Bio IncBLTE | 1 | Strong Buy | $132.00 | -3.96% | Maintains | a month ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Buy | $7.00 | +1,145.55% | Maintains | 2 months ago |
Unicycive Therapeutics IncUNCY | 1 | Buy | $21.00 | +224.57% | Maintains | 2 months ago |
Harvard Bioscience IncHBIO | 1 | Buy | $2.00 | +162.81% | Maintains | 3 months ago |
Clene IncCLNN | 1 | Strong Buy | $31.00 | +199.23% | Maintains | 3 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.